Source:http://linkedlifedata.com/resource/pubmed/id/10605951
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2000-3-1
|
pubmed:abstractText |
Cyclosporin A plays an important role in preventing rejection in allograft transplant recipients. However, the therapeutic use of cyclosporin A is associated with increased incidence of thromboembolic complications and drug-related hypertension. In order to study the mechanisms by which cyclosporin A induces these abnormal pathophysiological situations, we have assessed the platelet serotonin contents and whole blood platelet aggregation in control rats as well as in rats treated (orally) with 30 and 5 mg/kg/day of cyclosporin A, after 2 and 7 weeks of treatment. These doses correspond respectively to CsA "peak" and "trough" concentrations achieved in human blood in clinical practice (immediately following an intake of a daily dose of CsA and when the blood concentration stabilizes, respectively). Both trough and peak doses caused an increase in blood pressure after 2 and 7 weeks. Platelet serotonin content decreased in the cyclosporin-treated groups, in contrast with the control. Collagen-induced whole blood platelet aggregation increased drastically for the peak concentration-treated group, while adenosine 5'-diphosphate-induced platelet aggregation did not reach statistical significance. Finally, in vitro platelet thromboxane A2 generation increased in cyclosporin A concentrations when platelets were stimulated with either collagen or adenosine 5'-diphosphate. In conclusion, both tested cyclosporin A concentrations induced important changes in platelet serotonin and thromboxane content and aggregation, factors which may play a decisive role in the development and/or maintenance of hypertension and thrombotic complications.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane A2,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane B2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0049-3848
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
365-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10605951-Animals,
pubmed-meshheading:10605951-Blood Platelets,
pubmed-meshheading:10605951-Blood Pressure,
pubmed-meshheading:10605951-Cell Size,
pubmed-meshheading:10605951-Collagen,
pubmed-meshheading:10605951-Cyclosporine,
pubmed-meshheading:10605951-Hypertension,
pubmed-meshheading:10605951-Male,
pubmed-meshheading:10605951-Platelet Aggregation,
pubmed-meshheading:10605951-Platelet Count,
pubmed-meshheading:10605951-Rats,
pubmed-meshheading:10605951-Rats, Wistar,
pubmed-meshheading:10605951-Serotonin,
pubmed-meshheading:10605951-Thromboxane A2,
pubmed-meshheading:10605951-Thromboxane B2,
pubmed-meshheading:10605951-Time Factors
|
pubmed:year |
1999
|
pubmed:articleTitle |
The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats.
|
pubmed:affiliation |
Institute of Pharmacology and Experimental Therapeutics, Faculty of Medicine, Universidade de Coimbra, Portugal.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|